Final answer:
The pathophysiological process that promotes systemic lupus erythematosus (SLE) is the production of autoantibodies against nucleic acids and other self-components.
Step-by-step explanation:
Systemic Lupus Erythematosus (SLE) is promoted by the pathophysiological process of production of autoantibodies against nucleic acids and other self-components.
SLE is an autoimmune disease characterized by the immune system producing antibodies that target the body's own cells and tissues. These autoantibodies, including anti-nuclear antibodies (ANAs), anti-double-stranded DNA (ds-DNA), and anti-Sm antibodies, can lead to the formation of immune complexes and subsequent tissue damage.
This process of autoantibody production and immune complex formation is a hallmark of SLE and contributes to the chronic inflammation and multi-organ involvement seen in the disease.